Abstract:CRISPR-Cas systems are widely used for genome engineering technologies, and in their natural setting, they play crucial roles in bacterial and archaeal adaptive immunity, protecting against phages and other mobile genetic elements. Previously we discovered bacteriophage-encoded Cas9-specific anti-CRISPR (Acr) proteins that serve as countermeasures against host bacterial immunity by inactivating their CRISPR-Cas systems 1 . We hypothesized that the evolutionary advantages conferred by anti-CRISPRs would drive the widespread occurrence of these proteins in nature 2–4 . We have identified new anti-CRISPRs using the bioinformatic approach that successfully identified previous Acr proteins 1 against Neisseria meningitidis Cas9 (NmeCas9). In this work we report two novel anti-CRISPR families in strains of Haemophilus parainfluenzae and Simonsiella muelleri , both of which harbor type II-C CRISPR-Cas systems 5 . We characterize the type II-C Cas9 orthologs from H. parainfluenzae and S. muelleri , show that the newly identified Acrs are able to inhibit these systems, and define important features of their inhibitory mechanisms. The S. muelleri Acr is the most potent NmeCas9 inhibitor identified to date. Although inhibition of NmeCas9 by anti-CRISPRs from H. parainfluenzae and S. muelleri reveals cross-species inhibitory activity, more distantly related type II-C Cas9s are not inhibited by these proteins. The specificities of anti-CRISPRs and divergent Cas9s appear to reflect co-evolution of their strategies to combat or evade each other. Finally, we validate these new anti-CRISPR proteins as potent off-switches for Cas9 genome engineering applications.

Diverse mechanisms of CRISPR-Cas9 inhibition by type II anti-CRISPR proteins

Anti-CRISPR proteins targeting the CRISPR-Cas system enrich the toolkit for genetic engineering

Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems

Structure-based functional mechanisms and biotechnology applications of anti-CRISPR proteins

Type II-C CRISPR-Cas9 Biology, Mechanism, and Application

Anti-CRISPR: discovery, mechanism and function

Potent Cas9 inhibition in bacterial and human cells by new anti-CRISPR protein families

Anti-CRISPR protein applications: natural brakes for CRISPR-Cas technologies

Anti-CRISPR AcrIIA5 Potently Inhibits All Cas9 Homologs Used for Genome Editing

Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type IIC Anti-CRISPR Proteins

Systematic discovery of natural CRISPR-Cas12a inhibitors

Structural insights into the inactivation of the type I-F CRISPR-Cas system by anti-CRISPR proteins

The Expanding Class 2 CRISPR Toolbox: Diversity, Applicability, and Targeting Drawbacks

Disabling Cas9 by an anti-CRISPR DNA mimic

Discovery of potent and versatile CRISPR-Cas9 inhibitors engineered for chemically controllable genome editing

The CRISPR-Cas Mechanism for Adaptive Immunity and Alternate Bacterial Functions Fuels Diverse Biotechnologies

CRISPR/Cas9 Systems: The Next Generation Gene Targeted Editing Tool

Inhibition of CRISPR-Cas9 with Bacteriophage Proteins

Exploiting activation and inactivation mechanisms in type I-C CRISPR-Cas3 for genome-editing applications

A comprehensive appraisal of mechanism of anti-CRISPR proteins: an advanced genome editor to amend the CRISPR gene editing

Gene drive inhibition by the anti-CRISPR proteins AcrIIA2 and AcrIIA4 in Saccharomyces cerevisiae